Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.
Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check14 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for data selection and download options, while several key government health-related URLs have been removed.SummaryDifference14%
- Check36 days agoChange DetectedNew links have been added to the website, including major health and government resources such as HHS, NIH, NLM, NCBI, and USA.gov.SummaryDifference0.7%
- Check43 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options for data in various formats (CSV, JSON, RIS, FHIR) and allowing users to select specific fields for download.SummaryDifference16%
- Check50 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Lung Cancer Clinical Trial page.